Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction Assay  Janice.

Slides:



Advertisements
Similar presentations
Principles of Real-Time Quantitative PCR Techniques
Advertisements

A Genome-Wide High-Resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation  Lu Wang, Mamta Rao,
Pre-Clinical Validation of a Novel, Highly Sensitive Assay to Detect PML-RARα mRNA Using Real-Time Reverse-Transcription Polymerase Chain Reaction  James.
High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer  Yu Wu, Jamie R. Schoenborn, Colm Morrissey, Jing Xia, Sandy Larson, Lisha.
Simultaneous Genotyping of α-Thalassemia Deletional and Nondeletional Mutations by Real-Time PCR–Based Multicolor Melting Curve Analysis  Qiuying Huang,
One-Step Ligation on RNA Amplification for the Detection of Point Mutations  Lei Zhang, Jingjing Wang, Mia Coetzer, Stephanie Angione, Rami Kantor, Anubhav.
Locked Nucleic Acids Can Enhance the Analytical Performance of Quantitative Methylation-Specific Polymerase Chain Reaction  Karen S. Gustafson  The Journal.
Gene quantification using real-time quantitative PCR
Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe–Based Single-
Whole Genome Amplification for Array Comparative Genomic Hybridization Using DNA Extracted from Formalin-Fixed, Paraffin-Embedded Histological Sections 
A Case of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia with a Rare FIP1L1 Breakpoint  Frédéric Lambert, Pierre Heimann, Christian Herens, Alain.
Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Ronald van Marion, Niels M
A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.
A Novel Technology for Multiplex Gene Expression Analysis Directly from Whole Blood Samples Stabilized at Ambient Temperature Using an RNA-Stabilizing.
MethySYBR, a Novel Quantitative PCR Assay for the Dual Analysis of DNA Methylation and CpG Methylation Density  Pang-Kuo Lo, Hanano Watanabe, Pi-Chun.
Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma  Esther M. van Wezel, Danny Zwijnenburg, Lily.
Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid  Tatsuo Hata, Marco Dal.
Establishment and Study of Different Real-Time Polymerase Chain Reaction Assays for the Quantification of Cells with Deletions of Chromosome 7  Elia Mattarucchi,
Angela Leo, Andrew M. Walker, Matthew S
B-Cell Clonality Determination Using an Immunoglobulin κ Light Chain Polymerase Chain Reaction Method  Reetesh K. Pai, Artemis E. Chakerian, John M. Binder,
FISH Analysis for the Detection of Lymphoma-Associated Chromosomal Abnormalities in Routine Paraffin-Embedded Tissue  Roland A. Ventura, Jose I. Martin-Subero,
Limitations and Practical Procedure in BclII-Ig Heavy Chain Gene Rearrangement Real- Time Quantitative Polymerase Chain Reaction  Barbara Dessars, Pierre.
Association of Clinical Status of Follicular Lymphoma Patients after Autologous Stem Cell Transplant and Quantitative Assessment of Lymphoma in Blood.
Multiplex Ligation-Dependent Probe Amplification
Copy Number Variation Sequencing for Comprehensive Diagnosis of Chromosome Disease Syndromes  Desheng Liang, Ying Peng, Weigang Lv, Linbei Deng, Yanghui.
Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc  Kelly G. Paulson, Bianca D. Lemos, Bin Feng, Natalia.
Comparative Genomic Hybridization Analysis of Astrocytomas
Karin D. Berg, Cynthia L. Glaser, Richard E. Thompson, Stanley R
DNA Diagnostics by Surface-Bound Melt-Curve Reactions
Customized Oligonucleotide Array-Based Comparative Genomic Hybridization as a Clinical Assay for Genomic Profiling of Chronic Lymphocytic Leukemia  Rachel.
Mucinous Differentiation Correlates with Absence of EGFR Mutation and Presence of KRAS Mutation in Lung Adenocarcinomas with Bronchioloalveolar Features 
Simultaneous Genotyping of α-Thalassemia Deletional and Nondeletional Mutations by Real-Time PCR–Based Multicolor Melting Curve Analysis  Qiuying Huang,
A Fast Real-Time Polymerase Chain Reaction Method for Sensitive and Specific Detection of the Neisseria gonorrhoeae porA Pseudogene  Stig Ove Hjelmevoll,
Establishment of Real-Time Polymerase Chain Reaction Method for Quantitative Analysis of Asparagine Synthetase Expression  Tamotsu Irino, Toshiyuki Kitoh,
Andrea Gaedigk, Amanda K. Riffel, J. Steven Leeder 
Low Copy Number DNA Template Can Render Polymerase Chain Reaction Error Prone in a Sequence-Dependent Manner  Mansour Akbari, Marianne Doré Hansen, Jostein.
Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence  Xiaoyu Qu, Claudio Jeldres, Lena Glaskova, Cynthia.
Multiplexed Detection of Anthrax-Related Toxin Genes
Molecular Cytogenetic Evidence for a Common Breakpoint in the Largest Inverted Duplications of Chromosome 15  A.E. Wandstrat, J. Leana-Cox, L. Jenkins,
A Genome-Wide High-Resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation  Lu Wang, Mamta Rao,
Use of Single Nucleotide Polymorphisms (SNP) and Real-Time Polymerase Chain Reaction for Bone Marrow Engraftment Analysis  Dwight H. Oliver, Richard E.
SNPitty The Journal of Molecular Diagnostics
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Rapid Next-Generation Sequencing Method for Prediction of Prostate Cancer Risks  Viacheslav Y. Fofanov, Kinnari Upadhyay, Alexander Pearlman, Johnny Loke,
Clinical Categories of Neuroblastoma Are Associated with Different Patterns of Loss of Heterozygosity on Chromosome Arm 1p  Jaume Mora, Nai-Kong V. Cheung,
Diagnostic Utility of Molecular Investigation in Extraskeletal Myxoid Chondrosarcoma  Stefania Benini, Stefania Cocchi, Gabriella Gamberi, Giovanna Magagnoli,
KRAS Mutation The Journal of Molecular Diagnostics
Gerald B. W. Wertheim, Catherine Smith, Maria E
Assessment of the Frequency of Allelic Imbalance in Human Tissue Using a Multiplex Polymerase Chain Reaction System  Christopher M. Heaphy, William C.
Efficient and Highly Sensitive Screen for Myotonic Dystrophy Type 1 Using a One-Step Triplet-Primed PCR and Melting Curve Assay  Mulias Lian, Indhu-Shree.
Molecular Monitoring of Chronic Myelogenous Leukemia
Renata C. Gallagher, Birgit Pils, Mohammed Albalwi, Uta Francke 
Consensus JH Gene Probes with Conjugated 3′-Minor Groove Binder for Monitoring Minimal Residual Disease in Acute Lymphoblastic Leukemia  Michihiro Uchiyama,
Defining Ploidy-Specific Thresholds in Array Comparative Genomic Hybridization to Improve the Sensitivity of Detection of Single Copy Alterations in Cell.
Accurate Detection of Copy Number Changes in DNA Extracted from Formalin-Fixed, Paraffin-Embedded Melanoma Tissue Using Duplex Ratio Tests  David A. Moore,
High-Throughput Identification and Quantification of Candida Species Using High Resolution Derivative Melt Analysis of Panfungal Amplicons  Tasneem Mandviwala,
High-Resolution Molecular Characterization of 15q11-q13 Rearrangements by Array Comparative Genomic Hybridization (Array CGH) with Detection of Gene Dosage 
Molecular and Fluorescence In Situ Hybridization Characterization of the Breakpoints in 46 Large Supernumerary Marker 15 Chromosomes Reveals an Unexpected.
Low Incidence of Minor BRAF V600 Mutation-Positive Subclones in Primary and Metastatic Melanoma Determined by Sensitive and Quantitative Real-Time PCR 
Gayatry Mohapatra, Rebecca A. Betensky, Ezra R
Katy Hanlon, Lorna W. Harries, Sian Ellard, Claudius E. Rudin 
A Pyrosequencing-Based Assay for the Rapid Detection of the 22q11
A Novel Multiplexing, Polymerase Chain Reaction-Based Assay for the Analysis of Chromosome 18q Status in Colorectal Cancer  Nadina Erill, Anna Colomer,
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
HPV Genotype Detection Using Hybrid Capture Sample Preparation Combined with Whole Genome Amplification and Multiplex Detection with Luminex XMAP  Brian.
Qing-Rong Chen, Gordon Vansant, Kahuku Oades, Maria Pickering, Jun S
Practical Bioinformatic DNA-Sequencing Pipeline for Detecting Oncogene Amplification and EGFRvIII Mutational Status in Clinical Glioblastoma Samples 
Volume 41, Issue 2, Pages (January 2011)
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification 
Quantification of bcl-2/JH Fusion Sequences and a Control Gene by Multiplex Real- Time PCR Coupled with Automated Amplicon Sizing by Capillary Electrophoresis 
Presentation transcript:

Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction Assay  Janice M. Nigro, Michelle A. Takahashi, David G. Ginzinger, Mark Law, Sandra Passe, Robert B. Jenkins, Ken Aldape  The American Journal of Pathology  Volume 158, Issue 4, Pages 1253-1262 (April 2001) DOI: 10.1016/S0002-9440(10)64076-X Copyright © 2001 American Society for Investigative Pathology Terms and Conditions

Figure 1 TaqMan chemistry and strategy for QuMA. A: Fluorescence is detected when the 5′-label of the probe, or reporter (R), is liberated from the 3′-quenching signal (Q) through the exonucleolytic activity of Taq polymerase. The probe for QuMA hybridizes to the CA repeat of microsatellite sequences. B: Schematic illustration of QuMA experiment comparing tumor DNA with loss (short-dashed lines) to normal DNA (long-dashed lines). The curves for the reference locus for two DNAs are superimposed and for simplicity are shown as a single curve (solid line). Comparison of each microsatellite curve with its appropriate reference is represented as the δCt, where δCt = Ct (microsatellite) − Ct (reference), and Ct is cycle number at threshold. The relative copy number (tumor to normal DNA) is determined from the δδCt, where δδCt = δCt (tumor) − δCt (normal). The copy number in the tumor DNA is equal to 2 × 2−δδCt. The American Journal of Pathology 2001 158, 1253-1262DOI: (10.1016/S0002-9440(10)64076-X) Copyright © 2001 American Society for Investigative Pathology Terms and Conditions

Figure 2 PCR efficiency of paraffin-embedded DNA. A: DNA from normal paraffin-embedded tissue was serially diluted starting at 50 ng, and a microsatellite locus from chromosome 1 was amplified. The diluted DNAs reach threshold as predicted from the fundamental equation for PCR, Xn = X0(1+E)n, or Xn = X02n when efficiency (E) is 100%. For example, the cycle difference at threshold for the 20 ng and 5 ng quantities is 2 reflecting the fourfold difference in starting DNA amounts. B: Plot of the log of input DNA quantities versus Ct. The equation for this line is derived from Xn = X0(1+E)nwhen n = Ct, cycle at threshold fluorescence. The efficiency of PCR can be calculated from the slope of the line, E = 10−1/slope − 1. Because the PCR efficiency is near 100% for all of our primer sets, the fundamental equation for PCR [Xn = X0(1+E)n] can be assumed to be Xn = X02n. In the experiment shown, the data points have a correlation of 0.9996 with E = 96% demonstrating that amplification of paraffin-embedded DNA over this range of input DNA closely adheres to the fundamental equation for PCR. The American Journal of Pathology 2001 158, 1253-1262DOI: (10.1016/S0002-9440(10)64076-X) Copyright © 2001 American Society for Investigative Pathology Terms and Conditions

Figure 3 Copy number of loci in tumors as determined by QuMA. Forty-one cases of oligodendroglioma or oligoastrocytoma have been ordered by the extent of 1p loss beginning with tumors where all five 1p loci have been deleted. Rows represent individual cases, and copy numbers for genomic loci (position indicated in cM) have been arranged in columns. Pathological diagnosis is designated as: O, oligodendroglioma; AO, anaplastic oligodendroglioma; OA, oligoastrocytoma; AOA, anaplastic oligoastrocytoma. Gain or loss is assigned to a copy number by using a tolerance interval as previously described. For these data, a calculated copy number <1.58 was scored as a loss, whereas >2.53 was scored as a gain. Calculated numbers are as indicated in theboxes, and dark-gray boxes represent losses, white boxes normal, and light gray boxes indicate gains. Boxes without numbers represent loci not determined. Locations of the FISH probes relative to 1p and 19q markers are also indicated at the top of the diagram. The American Journal of Pathology 2001 158, 1253-1262DOI: (10.1016/S0002-9440(10)64076-X) Copyright © 2001 American Society for Investigative Pathology Terms and Conditions

Figure 4 Histology and molecular results from FISH and QuMA for oligodendroglioma. A: Histology of a typical oligodendroglioma (case 8758) showing round nuclei, perinuclear halos, and chicken-wire vasculature. B: FISH showing loss of 1p36 (red signal) relative to 1q24 (green signal). C: Delay of one cycle in a tumor DNA relative to a normal DNA at D1S468. PCR is performed in triplicate for both the microsatellite and reference loci for each DNA so that each curve actually represents three curves. Because the reference curves (six curves total) for the normal and tumor DNA reach threshold at precisely the same cycle, this experiment directly illustrates 1p loss through the delay of one cycle at the threshold in a tumor DNA relative to a normal diploid DNA. The American Journal of Pathology 2001 158, 1253-1262DOI: (10.1016/S0002-9440(10)64076-X) Copyright © 2001 American Society for Investigative Pathology Terms and Conditions

Figure 5 QuMA and FISH results compared. FISH was performed on a subset of specimens from Figure 3 for comparison to QuMA results. Paraffin-embedded tumor sections were hybridized with probes for regions of loss on 1p and 19q. Hybridizations also included control probes from opposing arms, 1q and 19p, respectively, to create a ratio of total signals counted in 300 to 500 nuclei. Results are tabulated as nml for retention (two copies), del for loss (one copy), and gain for more than two copies. Chromosomal arms that were discordant between the two methods are shaded in the QuMA results. The American Journal of Pathology 2001 158, 1253-1262DOI: (10.1016/S0002-9440(10)64076-X) Copyright © 2001 American Society for Investigative Pathology Terms and Conditions

Figure 6 Correlation of 1p/19q status with histology. Photomicrographs (original magnification, ×400) of H&E-stained paraffin sections from three oligodendrogliomas (A–C) and a single oligoastrocytoma (D andE) are shown. A: Case 5457: round nuclei and perinuclear halos highlight this classic oligodendroglioma with 1p/19q loss. B: Case 2470: an anaplastic oligodendroglioma that does not display classic oligodendroglial morphology, but showing 1p/19q loss. C:Case 16223: glioma with some features of oligodendroglioma (round, regular nuclei) where 1p/19q has remained intact. D and E: Case 2286: oligoastrocytoma with 1p/19q loss that exhibits distinct areas of oligodendroglial (D) and astrocytic (E) morphology. The American Journal of Pathology 2001 158, 1253-1262DOI: (10.1016/S0002-9440(10)64076-X) Copyright © 2001 American Society for Investigative Pathology Terms and Conditions

Figure 7 1p loss detected by QuMA maps to a common region of deletion previously characterized in gliomas. QuMA detected partial deletions (loss of more than one consecutive marker) in four oligodendrogliomas (8503, 307, 7876, 10896). All of these tumors have lost the marker D1S214. The FISH probe that is centromeric to D1S468 was retained in tumor 8503 limiting the overlapping region of loss from the probe region to the marker D1S2736. Tumor 14670 with an isolated loss at D1S468 was included to illustrate that retention of the FISH probe in both 14670 and 8503 raises the possibility that deletions in these tumors both end within the region complementary to the probe. The American Journal of Pathology 2001 158, 1253-1262DOI: (10.1016/S0002-9440(10)64076-X) Copyright © 2001 American Society for Investigative Pathology Terms and Conditions